Market Synopsis
Market
Research Future (MRFR) speculates that the global Embolization Particle Market is slated to garner USD 1,909.76 million and
is estimated to demonstrate a notable CAGR of 9.64% during the forecast period
(2017-2023). The rising use of embolization technique as a treatment for
vascular malformations is highly influencing the market growth. Embolization is
referred to as a minimally invasive therapy to stop the blood flow into the
tumor to shrink its size and prepare it for removal. Embolized particles are
injected into the veins of the patients to reduce or block the flow of blood to
the cancer cells. It is an ideal option for the
patients with tumors which can be removed by surgery.
Market Potential and
Pitfalls
The
market’s course is chiefly directed by
the augmenting use of embolization technique as a treatment for cancer,
fibrosis, and vascular malformations. There has been a continuous introduction of technically advanced products with
enhanced efficiency, which is highly contributing to the growth of the market.
Embolization particles are extensively used
in treating malignancies like peripheral diseases and cancer. With the
increasing incidences of cancer across the globe, the embolization particles
market is presumed to flourish. As per the WHO, cancer is considered the second
prominent cause of death with maximum deaths occurring due to cancer.
Major
market players are continuously introducing technologically advanced products
which are highly supporting the growth of
embolization particles market. For instance, Sirtex introduced SIR-Spheres Y-90
resin microspheres in 2017 which serves as the first-line treatment for the
patients suffering from liver metastases from right-sided primary colon cancer.
Moreover, the growing awareness among the people is further leading to an
increased demand for embolization particle. Also, the growing number of
minimally invasive surgeries and increasing interventional procedure owing to
positive results are further contributing to the market growth.
On
the contrary, less number of interventional neuroradiology and interventional
neuroradiologists labs coupled with the strict regulatory mandates are some of
the major concerns considered to vitiate the market growth throughout the appraisal
period.
Browse Complete Report : https://www.marketresearchfuture.com/reports/embolization-particle-market-4815
Global Embolization Particle
Market: Segmental Analysis
The
global embolization particle market has been
segmented on the basis of
application, product type, level of occlusion, and end user.
By
mode of product type, the embolization particle market has been segmented into drug eluting beads and radioembolization.
By
mode of application, the embolization particle market has been segmented into urology, oncology,
neurology, peripheral vascular disease, and others. Among these, the peripheral
vascular disease is likely to dominate the global market owing to its rising
prevalence over the years.
By
mode of level of occlusion, the
embolization particle market has been segmented
into distal and proximal.
By
mode of end-user, the embolization particle market has been segmented into ambulatory services, hospitals & clinics,
and others. Among these, the hospital's
segment is predicted to constitute a major share as people mostly prefer to
visit hospitals for diagnosis and treatment.
Regional Insights
Geographically,
the embolization particle market span across regions namely, Europe, America,
Asia Pacific, and the Middle East & Africa.
Considering the global scenario, the American region is considered to dominate the global
embolization particle market. The presence of
a strong economic condition, the high
focus of the research institutes on updating technologies for advanced
treatment and diagnosis methods, and continuous development in the healthcare
sector are influencing the market growth.
Additionally, the availability of healthcare professionals and advanced
hospital infrastructures are likely to influence the market growth in this
region.
The
European region holds the second position
owing to the changing lifestyle, rapid diagnosis & treatment and diagnosis of cancer, and rising prevalence of
cancer, especially among the geriatric
population. According to the Organization for
Economic Co-operation & Development, in 2013 Germany had spent
almost 11% of the total GDP on healthcare. This
has further influenced the market growth to a large extent.
The Asia Pacific region will expand at the fastest rate and is likely to retain its growth in the
coming years. The growth is mainly due to the
presence of developing nations such as China and India in this region. A
major chunk of the population from these nations are suffering from cancer
which has increased the demand for diagnosis and treatment. Such factors are
highly influencing the market growth throughout the appraisal period.
Industry Updates
November
30, 2018: Merit Medical has recently received FDA clearance of 510(k) for its
EmboCube embolization gelatin. Used in the embolization of hypervascular
tumors, EmboCube features cubes of gelatin foam which are uniformly cut and
have been specifically designed to address inconsistent particle sizes and
preparation concerns that come with traditional gelatin foam sheets as an
embolic.
Competitive Dashboard
The
prominent players operating in the embolization particle market are Sirtex,
Terumo, BTG International Ltd, Boston Scientific Corporation, Medtronics, Merit Medical, and Guerbet.
No comments:
Post a Comment